Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
News
Wang Luo
2024,08,23
Continuously deepening and refining market and brand promotion, Cheng Yi Pharmaceutical's revenue in the first half of the year increased by 10.89% year-on-year
Data Treasure
2024,08,21
List of long-term heavy holdings of social security funds exposed
Popular Securities News
2024,08,21
Cheng Yi Pharmaceutical: Strong Core Product Power, Revenue Increased by 10.89% YoY in the First Half of the Year
Cheng Yi
Company notice
Company news
Media coverage
2020,03,14
Deeply cultivate the big health industry; Promote improvement of quality and efficiency
2020,02,26
Cheng Yi Pharmaceutical's "Ribavirin" campaign to aid epidemic areas
2020,02,22
Sincere Pharmaceutical's "Ribavirin" Assistance to Epidemic Areas
2020,02,20
Zheng Cheng Yi Pharmaceutical 100 Person Disinfection Exercise
2020,02,18
Cheng Yi Pharmaceutical Comprehensive Epidemic Prevention
2020,02,16
Cheng Yi Pharmaceutical Resumption of Work and Epidemic Prevention
2020,02,10
Cheng Yi Pharmaceutical Donates Supplies to Zhejiang Charity Federation
2020,02,05
Ribavirin was selected into the diagnosis and treatment scheme of COVID-19
2020,02,05
District leaders sent congratulatory letters to Cheng Yi Pharmaceutical
2020,01,18
The book "From the Sea to Shanghai" was published
2019,12,25
The Legendary Life of Yan Yiyi, the Leader of Cheng Yi Pharmaceutical
2019,12,10
Cheng Yi Pharmaceutical always adheres to the driving force of innovation
<
1
...
7
8
9
...
16
>
Contact Us
view more